Today’s standout insider activity comes with plenty to unpack.

Warren Buffett’s Berkshire Hathaway is back at it, revealing a fresh $28.5 million purchase in VeriSign $VRSN.

When Uncle Warren makes a move, it’s always worth watching.

Over at Progyny $PGNY, both the CEO and the Executive Chairman stepped in to buy their own stock.

Seeing top leadership align like this is a rare and notable signal.

Here’s The Hot Corner, with data from December 26, 2024:

Meanwhile, Third Point disclosed a 13G filing for Telephone and Data Systems $TDS, revealing an original stake of 5.70%.

Finally, executives from several other companies also made significant purchases:

• Agree Realty Corporation $ADC;
• ...

Today’s standout insider activity features some intriguing moves across key players.

Director Neil de Crescenzo made waves with a Form 4 filing, snapping up 100,000 shares of CCC Intelligent Solutions Holdings $CCCS—a significant bet on the company’s future. 

Meanwhile, at Ardelyx $ARDX, director David Mott—on the board since 2009—dropped a cool $1 million on shares, a bold show of conviction.

Here’s The Hot Corner, with data from December 23, 2024:

Over at Arthur J. Gallagher & Co $AJG, the COO joined the action, purchasing 1,115 shares—a subtle but telling vote of confidence from the executive suite.

Rounding out the action, insider buying also surfaced at Lowe’s Companies $LOW, The Lovesac Company $LOVE, and FB Financial Corporation $FBK, hinting at optimism in a diverse set of industries.

Today’s most notable insider transaction comes via a Form 4 filing from Control Empresarial de Capitales S.A.

The firm disclosed another increase in its ownership stake in PBF Energy $PBF. They now own 28,814,998 shares, representing more than a 25% interest.

Here’s The Hot Corner, with data from December 20, 2024:

Adding to the action, Director Arjun Murti disclosed the purchase of 2,500 shares of ConocoPhillips $COP. 

While smaller in scale, these transactions indicate an insider's belief in the value or potential upside of the company.

Despite a rough couple of months for the entire sector, energy names are popping up on our radar a lot lately.

Even Warren Buffett is buying this dip. After a six-month pause, Berkshire Hathaway reported another purchase of Occidental Petroleum $OXY...

Uncle Warren is back in the buying game.

When Warren Buffett and Berkshire Hathaway start buying, it’s time to sit up and take notice. 

The Oracle of Omaha has returned to the open market with three intriguing purchases. Let’s dive into them.

First up, Occidental Petroleum $OXY. After a six-month hiatus, Buffett is back, snapping up shares. This marks the 29th Form 4 filing for OXY since he began building his position in early 2022. 

Berkshire shelled out $400 million this time, bringing Buffett’s average purchase price to $54.02. 

Here’s a chart highlighting the timing of Buffett’s $OXY purchases:

Next, Sirius XM Holdings $SIRI. Berkshire stepped in with a $107.2 million investment in the satellite radio giant. 

He now owns 117,468,573 shares, equivalent to 34.6% stake.

Here’s...

Leading today’s list is Ariel Emanuel, CEO of TKO Group Holdings $TKO, making waves with an eye-popping $77 million purchase. 

When a CEO drops this kind of cash on their own stock, it screams confidence in the company’s future.

Kenneth Courtis, independent director of Alpha Metallurgical Resources $AMR, followed suit with a hefty $2.4 million buy. Insider moves like this often hint at good things to come, or at least an upward move in the stock.

Here’s The Hot Corner, with data from December 18, 2024:

ConocoPhillips $COP saw action too, as director R.A. Walker scooped up 10,400 shares in the latest Form 4 filing.

But that’s not all. The president and CEO of 3D Systems Corporation $DDD, Jeffrey Graves, doubled down with a bold move, snapping up 60,000 shares of his own company’s stock.

Baker Bros Advisors, renowned for their biotech expertise, increased their stake in Bicycle Therapeutics $BCYC from 19.76% to 22.90%, as disclosed in a 13D filing. 

This signals strong confidence in the company's prospects, likely tied to its innovative "Bicycles" platform for developing novel therapies. 

Given the Bakers' track record, their investment is a notable endorsement of Bicycle Therapeutics' potential. 

In essence, when the Bakers buy, biotech investors pay attention.

Here’s The Hot Corner, with data from December 17, 2024:

Two notable insider purchases were disclosed via Form 4 filings in the energy sector:

• PBF Energy Inc $PBF: Control Empresarial de Capitales SA reported a purchase, adding $5,357,162 to its current position.
• Diamondback Energy $FANG: Director Steven West also disclosed buying shares for $975,960.

The standout insider move today comes from Eric Schuppenhauer, an executive VP at SoFi Technologies $SOFI.

Schuppenhauer made a bold statement by purchasing 30,599 SOFI shares—an investment worth $500,000.

This adds weight to the vision of CEO Anthony Noto, who demonstrated his confidence with $10 million in insider buys between March 2022 and May 2024.

The stock has officially left the station, completing a classic bottoming formation and now surging higher with authority:

Price is currently breaking out of a tight continuation pattern, in the direction of the underlying trend.

If insiders are anything to go by, they clearly believe there’s still plenty of track ahead for this train!

Here’s The Hot Corner, with data from December 16, 2024:

James Monroe III, a director and significant shareholder of Globalstar $GSAT, revealed a...

The largest insider buy on today’s list comes via a Form 4 filing by TKO Group $TKO director Egon Durban.

Durban revealed a massive purchase of TKO shares for a total value of $48,133,338.

Durban currently serves as CEO of Silver Lake and is the chairman of Endeavor Group, the majority shareholder of TKO.

Stellantis is back with another large investment in Archer Aviation Inc $ACHR.

The automaker just revealed the acquisition of 751,879 shares, equivalent to $5 million.

Here’s The Hot Corner, with data from December 13, 2024:

Control Empresarial de Capitales SA continues to buy PBF Energy $PBF shares, reporting a purchase in the amount of $8,460,732.

Last but not least, there were also insider buys reported from directors of Terex Corporation $TEX, Dillard's $DDS, and Pulse Biosciences $PLSE.

Jack L. Macdowell, chief investment officer of Chimera Investment Corporation $CIM, acquired $998,580 worth of CIM shares.

Kevin M. Sheehan, Interim CEO of Dave & Buster's Entertainment $PLAY, purchased 37,735 shares.

Here’s The Hot Corner, with data from December 12, 2024:

Director Mark A. Weinberger acquired 1,000 shares of Johnson & Johnson $JNJ.

We also witnessed insider buys in Hubbell Incorporated $HUBB and Jackson Financial $JXN.

OPKO Health $OPK CEO Phillip Frost just put his money where his mouth is, snapping up 500,000 of OPK shares at $1.56 each.

Remember, executives sell for many reasons. But they only buy because they believe in their company and think it will have a higher stock price in the future.

Frost is clearly placing his chips on OPKO’s future.

Here’s The Hot Corner, with data from December 11, 2024:

Director David B. Smith, Jr. bought 635 shares of Illinois Tool Works $ITW, equivalent to $174,752.

ARK Investment Management is making waves with its latest move.

In a recent 13G filing, Cathie Wood and her team increased their stake in CRISPR Therapeutics AG $CRSP from 8.78% to 10.69%.

This move makes CRSP the fifth largest holding in ARK’s portfolio, highlighting their strong belief in the company and its groundbreaking work in gene editing.

Every time ARK Investment Management makes a move, it’s worth paying attention – and their latest activity is no exception.

Here’s The Hot Corner, with data from December 10, 2024:

Adding to the activity, GIC Private Ltd., Singapore's sovereign wealth fund, disclosed an initial 5.66% stake in Paymentus Holdings $PAY in a schedule 13G.

Last but not least, we witnessed insider activity in PBF Energy $PBF, Matador Resources Company $MTDR and Biglari Holdings Inc $BH.

Thilo Schroeder, director of Revolution Medicines $RVMD and managing member of Nextech Invest, made waves with a $60 million insider buy, acquiring 1.3 million shares.

Nextech, known for investing in cutting-edge life sciences companies, often backs transformative players in oncology. 

Schroeder's move underscores his confidence in RVMD’s potential.

Here’s The Hot Corner, with data from December 9, 2024:

Kevin Tang, President of Tang Capital Management, filed a Form 4 revealing a $10,822,000 purchase in Aurinia Pharmaceuticals Inc $AUPH.

Last but not least, the CEOs of MSCI Inc $MSCI and Biglari Holdings Inc $BH both filed Form 4s, revealing purchases of their own stock.